25.000
+0,00%
2026-10-07
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +0.3% | +62.0% | 3 / 3 | +39.6% | +3.75 pp | -11.98 pp | 0.0% | 0.00 | 10.91 | 20,9 | +39,6% | 6,4 | +0,3% | 10.91 | 13.18 | −17,2% |
| Pts | 0 | 12 | 12 | 12 | 12 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 25.000 (close price on 2026-10-07)EPS (TTM): 2.292
Financial charts
1.Revenue & growth
VND bn20,9Q2/26
1.Revenue & growth
VND bn20,9Q2/26
2.Profit & growth
VND bn6,46Q2/26
3.Profit mix (Penman)
VND bn57,8Q2/26
4.Margins & cost structure
%29.5%Q2/26
5.Returns & cash cycle
% · days6.0%Q2/26
6.Earnings quality & cash
VND bn77,3Q2/26
7.Asset structure
VND bn609Q2/26
8.Funding & debt health
VND bn · times609Q2/26
9.Revenue backlog
VND bn0,08Q2/26
10.Valuation
times · %10,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %313Q2/26
Adjusted EPS growth, latest quarter
1.5%
Average adjusted EPS growth, 3 quarters
62.4%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26